Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
Global Gastric Cancer Forecast and Market Analysis 2017-2024: Forecasts, Treatment, Epidemiology, Marketed Drugs, Pricing & Reimbursement and Piepline | ||
By: PR Newswire Association LLC. - 16 Feb 2018 | Back to overview list |
|
DUBLIN, Feb. 16, 2018 /PRNewswire/ -- The "Gastric Cancer Forecast and Market Analysis to 2024" report has been added to ResearchAndMarkets.com's offering. Gastric cancer is the second-leading cause of cancer-related mortality worldwide. There is significant geographic variation in the burden of the disease: incidence and mortality are notably high in East Asia, China, Eastern Europe, and Latin America, whereas the disease is no longer as common in North America and Western Europe. Globally, there has been a steady decline in incidence over the past 50 years. This is mostly attributable to the decline in prevalence of H. pylori infections, a decline in tobacco use, and improvements in food preservation and diet. Market Snapshot
Key Topics Covered:
Treatment: Gastric Cancer
Epidemiology: Gastric Cancer In The Us, Japan, And 5EU
Marketed Drugs: Gastric Cancer
Gastric Cancer Pricing, Reimbursement, And Access
For more information about this report visit https://www.researchandmarkets.com/research/2hr9mn/global_gastric?w=5 Media Contact: Laura Wood, Senior Manager SOURCE Research and Markets |
||
|
||
Copyright 2018 PR Newswire Association LLC. | Back to overview list |